Publications

1. Vora SA, Wong WW, Schild SE, Ezzell GA, Andrews PE, Ferrigni RG, Swanson SK. 9-Year Outcome and Toxicity in Patients Treated with Intensity Modulated Radiation Therapy for Localized Prostate Cancer. J Urol. 2013 Feb 13. [Epub ahead of print] 2304032
   View PubMed
2. Paripati HR, Karlin NJ, Schild SE, Vora SA, Dueck AC, Ross HJ. Multimodality therapy improves survival in elderly patients with locally advanced non-small cell lung cancer-A retrospective analysis. Journal of Geriatric Oncology. 2012; 3(2):104-10. 2238252
   
3. Wong WW, Schild SE, Vora SA, Ezzell GA, Nguyen BD, Ram PC, Roarke MC. Image-guided radiotherapy for prostate cancer: a prospective trial of concomitant boost using indium-111-capromab pendetide (ProstaScint) imaging. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):e423-9. Epub 2011 Apr 07. 2157467
   View PubMed
4. Vora SA. Normal tissue toxicity thoracic malignancies. Radiation Medicine Rounds. 2010:25-38. 2122945
   
5. Wong WW, Vora SA, Schild SE, Ezzell GA, Andrews PE, Ferrigni RG, Swanson SK. Radiation dose escalation for localized prostate cancer: intensity-modulated radiotherapy versus permanent transperineal brachytherapy. Cancer. 2009 Dec 1; 115(23):5596-606. 1957527
   View PubMed
6. Nguyen BD, Schild SE, Wong WW, Vora SA. Prostate brachytherapy seed embolization to the right renal artery. Brachytherapy. 2009 Jul-Sep; 8(3):309-12. Epub 2009 Feb 12. 1923923
   View PubMed
7. Schild MH, Wong WW, Vora SA, Ward LD, Nguyen BD. Embolization of an iodine-125 radioactive seed from the prostate gland into the right ventricle: An unusual pattern of seed migration. Radiography. 2009; 15(2):179-81. 1978623
   View PubMed
8. Lyons MK, Vora SA. Brain tumors: current issues in diagnosis and management. Semin Neurol. 2007 Sep; 27(4):312-24. 1841505
   View PubMed
9. Vora SA, Wong WW, Schild SE, Ezzell GA, Halyard MY. Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2007 Jul 15; 68(4):1053-8. Epub 2007 Mar 29. 1832958
   View PubMed
10. Halyard MY, Jatoi A, Sloan JA, Bearden JD 3rd, Vora SA, Atherton PJ, Perez EA, Soori G, Zalduendo AC, Zhu A, Stella PJ, Loprinzi CL. Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4). Int J Radiat Oncol Biol Phys. 2007 Apr 1; 67(5):1318-22. 1818768
    View PubMed
11. Schild SE, Wong WW, Vora SA, Halyard MY, Northfelt DW, Kogut HL, Wheeler RH. The long-term results of a pilot study of three times a day radiotherapy and escalating doses of daily cisplatin for locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2005 Aug 1; 62(5):1432-7. 1726757
    View PubMed
12. Schwartz DJ, Schild SE, Wong WW, Vora SA. Factors associated with the frequency of self-intermittent catheterization after prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2005 Jan 1; 61(1):60-3. 1680793
    View PubMed
13. MacDonald OK, Schild SE, Vora S, Andrews PE, Ferrigni RG, Novicki DE, Swanson SK, Wong WW. Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ? Urology. 2004 Oct; 64(4):760-4. 1674417
    View PubMed
14. Wong WW, Schild SE, Vora SA, Halyard MY. Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2004 Sep 1; 60(1):24-9. 1665796
    View PubMed
15. Schild SE, Korte SM, Wong WW, Vora SA, Younggren JA, Ezzell GA. Treatment planning for dose escalation in non-small cell lung cancer (NSCLC). Med Dosim. 2004 Fall; 29(3):196-203. 1674083
    View PubMed
16. Halyard MY, McCombs KE, Wong WW, Buchel EW, Pockaj BA, Vora SA, Gray RJ, Schild SE. Acute and chronic results of adjuvant radiotherapy after mastectomy and Transverse Rectus Abdominis Myocutaneous (TRAM) flap reconstruction for breast cancer. Am J Clin Oncol. 2004 Aug; 27(4):389-94. 1662237
    View PubMed
17. Macdonald OK, Schild SE, Vora SA, Andrews PE, Ferrigni RG, Novicki DE, Swanson SK, Wong WW. Salvage radiotherapy for palpable, locally recurrent prostate cancer after radical prostatectomy. Int J Radiat Oncol Biol Phys. 2004 Apr 1; 58(5):1530-5. 1641346
    View PubMed
18. Vora SA, Garner SL. Role of radiation therapy for facial skin cancers. Clin Plast Surg. 2004 Jan; 31(1):33-8. 1639059
    View PubMed
19. Macdonald OK, Schild SE, Vora SA, Andrews PE, Ferrigni RG, Novicki DE, Swanson SK, Wong WW. Radiotherapy for men with isolated increase in serum prostate specific antigen after radical prostatectomy. J Urol. 2003 Nov; 170(5):1833-7. 1420009
    View PubMed
20. Schild SE, Wong WW, Vora SA, Halyard MY, Wheeler RH. Phase I study of hyperfractionated accelerated radiotherapy and escalating doses of daily cisplatin for patients with locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2002 Nov 1; 54(3):729-34. 1316716
    View PubMed
21. Serago CF, Chungbin SJ, Buskirk SJ, Ezzell GA, Collie AC, Vora SA. Initial experience with ultrasound localization for positioning prostate cancer patients for external beam radiotherapy. Int J Radiat Oncol Biol Phys. 2002 Aug 1; 53(5):1130-8. 1315107
    View PubMed
22. Safran H, Moore T, Iannitti D, Dipetrillo T, Akerman P, Cioffi W, Harrington D, Quirk D, Rathore R, Cruff D, Vakharia J, Vora SA, Savarese D, Wanebo H. Paclitaxel and concurrent radiation for locally advanced pancreatic cancer. International Journal Radiation Oncology Biol Physics. 2001; 49(5):1275-9. 1689699
    
23. Vora SA, Daly BD, Blaszkowsky L, McGrath JJ, Bankoff M, Supran S, Dipetrillo TA. High dose radiation therapy and chemotherapy as induction treatment for stage III nonsmall cell lung carcinoma. Cancer. 2000 Nov 1; 89(9):1946-52. 1011551
    View PubMed
24. Vora SA, Wazer DE, Homer MJ. Management of microcalcifications that develop at the lumpectomy site after breast-conserving therapy. Radiology. 1997 Jun; 203(3):667-71. 1015423
    View PubMed
25. Mangan DF, Novak MJ, Vora SA, Mourad J, Kriger PS. Lectinlike interactions of Fusobacterium nucleatum with human neutrophils. Infection & Immunity. 1989 Nov; 57(11):3601-11. 1044947
    View PubMed